Cubist Systematic Strategies’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-32,335
| Closed | -$489K | – | 3930 |
|
|
2022
Q3 | $489K | Buy |
32,335
+5,313
| +20% | +$80.3K | ﹤0.01% | 2511 |
|
|
2022
Q2 | $203K | Sell |
27,022
-82,588
| -75% | -$620K | ﹤0.01% | 3158 |
|
|
2022
Q1 | $997K | Sell |
109,610
-346,417
| -76% | -$3.15M | 0.01% | 2025 |
|
|
2021
Q4 | $3.2M | Buy |
+456,027
| New | +$3.2M | 0.03% | 973 |
|
|
2021
Q2 | – | Sell |
-72,413
| Closed | -$1.29M | – | 3189 |
|
|
2021
Q1 | $1.29M | Sell |
72,413
-20,505
| -22% | -$366K | 0.02% | 1362 |
|
|
2020
Q4 | $1.26M | Sell |
92,918
-32,977
| -26% | -$445K | 0.02% | 1226 |
|
|
2020
Q3 | $1.48M | Sell |
125,895
-17,832
| -12% | -$210K | 0.02% | 1092 |
|
|
2020
Q2 | $2.12M | Buy |
143,727
+44,420
| +45% | +$656K | 0.04% | 753 |
|
|
2020
Q1 | $1.34M | Sell |
99,307
-28,183
| -22% | -$381K | 0.04% | 657 |
|
|
2019
Q4 | $3.08M | Buy |
127,490
+79,464
| +165% | +$1.92M | 0.06% | 517 |
|
|
2019
Q3 | $923K | Sell |
48,026
-708
| -1% | -$13.6K | 0.02% | 1005 |
|
|
2019
Q2 | $1.44M | Buy |
+48,734
| New | +$1.44M | 0.03% | 844 |
|
|
2019
Q1 | – | Sell |
-16,542
| Closed | -$597K | – | 2473 |
|
|
2018
Q4 | $597K | Sell |
16,542
-6,110
| -27% | -$221K | 0.03% | 849 |
|
|
2018
Q3 | $1.39M | Buy |
+22,652
| New | +$1.39M | 0.08% | 327 |
|
|
2017
Q4 | – | Sell |
-8,106
| Closed | -$394K | – | 2156 |
|
|
2017
Q3 | $394K | Buy |
+8,106
| New | +$394K | 0.02% | 977 |
|
|
2017
Q2 | – | Sell |
-13,300
| Closed | -$603K | – | 1936 |
|
|
2017
Q1 | $603K | Buy |
+13,300
| New | +$603K | 0.04% | 557 |
|
|
2016
Q1 | – | Sell |
-1,299
| Closed | -$32K | – | 1900 |
|
|
2015
Q4 | $32K | Buy |
+1,299
| New | +$32K | ﹤0.01% | 1646 |
|
|
2015
Q1 | – | Sell |
-1,300
| Closed | -$38K | – | 2132 |
|
|
2014
Q4 | $38K | Buy |
+1,300
| New | +$38K | ﹤0.01% | 1792 |
|